What is the recommended target mean arterial pressure (MAP) for patients with intracranial hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MAP Target for Intracranial Hemorrhage

For patients with intracranial hemorrhage, maintain a mean arterial pressure (MAP) > 80 mmHg, which corresponds to a systolic blood pressure target of 130-150 mmHg in spontaneous ICH or SBP > 100 mmHg in traumatic brain injury with hemorrhage.

Context-Specific Targets

The MAP target differs based on the type of intracranial hemorrhage and clinical scenario:

Traumatic Brain Injury with Intracranial Hemorrhage

  • Maintain MAP > 80 mmHg (or SBP > 100 mmHg) during interventions for life-threatening hemorrhage or emergency neurosurgery 1
  • This target applies specifically to patients with combined hemorrhagic shock and severe traumatic brain injury 2
  • In cases of difficult intraoperative bleeding control, lower values may be tolerated for the shortest possible time 1
  • Once ICP monitoring is available, maintain cerebral perfusion pressure (CPP) ≥ 60 mmHg, which should be individualized based on neuromonitoring data and cerebral autoregulation status 1

Spontaneous Intracerebral Hemorrhage (Non-Traumatic)

The approach for spontaneous ICH focuses on systolic blood pressure rather than MAP, but the principles translate to MAP management:

  • Target SBP of 130-150 mmHg (approximately MAP 90-110 mmHg) is recommended for mild to moderate ICH presenting with SBP 150-220 mmHg 3
  • Specifically, acute lowering to a target SBP of 140 mmHg with maintenance in the 130-150 mmHg range is safe and may improve functional outcomes 3
  • Avoid aggressive reduction to SBP < 130 mmHg (MAP < 90 mmHg), as this is potentially harmful 3
  • The older 2007 AHA/ASA guideline recommended maintaining MAP < 130 mmHg, but this has been superseded by more recent evidence 4

Critical Implementation Principles

Timing and Titration

  • Initiate blood pressure treatment within 2 hours of ICH onset and reach target within 1 hour to reduce hematoma expansion risk and improve functional outcomes 3
  • Careful titration is essential to ensure continuous, smooth, and sustained BP control while avoiding peaks and large variability 3
  • Use intravenous agents with rapid onset and short duration to facilitate easy titration 3

Key Safety Considerations

Common Pitfalls to Avoid:

  • Excessive BP reduction (> 20% relative reduction) is associated with renal adverse events, brain ischemia, and worse outcomes 5
  • Hypotension (SBP < 140 mmHg requiring vasopressor initiation) independently predicts renal adverse events 5
  • Rapid, uncontrolled BP decline during acute hospitalization is associated with increased mortality 4, 6

Cerebral Perfusion Pressure Priority

  • Always preserve CPP > 60 mmHg regardless of the blood pressure target chosen 4, 6
  • This is critical because overaggressive BP reduction may decrease CPP and worsen brain injury, particularly with elevated ICP 4, 6
  • Experience from both traumatic and spontaneous ICH supports this CPP threshold 4, 6

Special Populations

Large or Severe ICH

  • The safety and efficacy of intensive BP lowering are not well established in patients with large/severe ICH or those requiring surgical decompression 3
  • Exercise greater caution with BP reduction in these patients 3

Patients with Concurrent Hemorrhagic Shock

  • In polytrauma patients with both systemic hemorrhage and brain injury, the MAP > 80 mmHg target takes precedence during interventions 2, 1
  • This balances the need for cerebral perfusion with hemorrhage control 2, 1

Evidence Quality Note

The 2022 AHA/ASA guideline 3 represents the most recent high-quality evidence for spontaneous ICH, superseding the 2007 recommendations 4. The ATACH-2 trial 7 demonstrated that intensive SBP reduction to 110-139 mmHg did not improve outcomes compared to standard treatment (140-179 mmHg), supporting more conservative targets. The 2019 WSES consensus 1 provides the strongest guidance for traumatic brain injury with hemorrhage, with high agreement rates (82.5-100%) among experts.

Related Questions

What is the target mean arterial pressure (MAP) for a patient with acute hypertensive intracerebral hemorrhage?
What are the recommended treatment parameters for controlling systolic blood pressure in adult patients with acute intracranial hemorrhage?
What medications are recommended to treat persistent hiccups in a postoperative patient with an intracranial hemorrhage secondary to a motor vehicle accident?
What is the most likely diagnosis for an acute left parietal lobe intracerebral hemorrhage seen on CT?
Are there any guidelines permitting a one‑year rest period with comprehensive neurologic evaluation to replace a mandatory medical suspension for a boxer who has sustained an intracranial hemorrhage?
Is upadacitinib safe to use during pregnancy, and should it be discontinued before conception?
What are the recommended components, including history, physical exam, preventive screenings, immunizations, and counseling, for a Medicare Annual Wellness Visit in a 74‑year‑old female?
In a 60-year-old woman on dapagliflozin who presents with euglycemic ketoacidosis, should I use a point‑of‑care serum beta‑hydroxybutyrate (BHB) meter instead of urine ketone strips to assess ketosis?
What are the latest renal biomarkers for early detection and risk stratification of acute kidney injury, and how should they be used?
Can Florastor (Saccharomyces boulardii) cause loose stools?
What is the likelihood of developing oral candidiasis (thrush) in a patient taking systemic prednisone and azithromycin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.